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Purpose
Myofascial trigger points are a common component of
musculoskeletal neck pain. Capsaicin, a vanilloid 1
(TRPV1) receptor agonist, has been shown to induce
pain in human tendon tissues and to increase trigger
point sensitivity in humans. TRPV1 receptor agonists,
with repeated use, inhibit the initiation of transmission of
pain-related neurotransmitters and may alleviate pain.
This study evaluated the efficacy of a hydrogel patch con-
taining capsaicin 0.1% compared to a placebo hydrogel
patch without capsaicin to treat chronic myofascial neck
pain.
Methods
Sixty-one subjects between the ages of 18 and 65 years old
with at least 3 months of myofascial neck pain were
recruited. Participants were randomized to apply either
capsaicin 0.1% (500mcg) hydrogel patches or hydrogel
control patches without capsaicin to each side of the neck
and shoulder girdle area for 12 hours each day for a
4-week treatment period. The following instruments were
administered at baseline, at 2-weeks after the start of treat-
ment, at the conclusion of the 4-week treatment, and 4
weeks after the treatment period: (1) change on a visual
analogue scale (VAS), the primary outcome measure; (2)
Neck Disability Index (NDI); (3) Beck’s Depression inven-
tory (BDI); (4) Short Form 36 (SF-36) Korean version; and
(5) Euroqol 5-D(EQ-5D) Health Questionnaire.
Results
Fifty-seven subjects completed the study. The mean
VAS scores were significantly decreased at 2, 4 and
8 weeks after the start of the intervention in both
groups. However, there was no significant difference in
VAS score between the two groups or in any of the
other outcome measures.
Conclusion
Given the finding that subjects had a statistically signifi-
cant improvement with the 0.1% capsaicin hydrogel
patch compared to baseline, further studies may be war-
ranted. Future investigation may assess capsaicin as an
adjunct to the treatment of myofascial neck pain with
other self-care, medication, and office based approaches.
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